5-methyl-11-(3-piperidin-1-yl-propylamino)-10H-indolo[3,2-b]quinolin-5-ium chloride

ID: ALA404523

Chembl Id: CHEMBL404523

PubChem CID: 44446434

Max Phase: Preclinical

Molecular Formula: C24H29ClN4

Molecular Weight: 373.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[n+]1c2ccccc2c(NCCCN2CCCCC2)c2[nH]c3ccccc3c21.[Cl-]

Standard InChI:  InChI=1S/C24H28N4.ClH/c1-27-21-13-6-4-11-19(21)22(25-14-9-17-28-15-7-2-8-16-28)23-24(27)18-10-3-5-12-20(18)26-23;/h3-6,10-13H,2,7-9,14-17H2,1H3,(H,25,26);1H

Standard InChI Key:  IUGDDBKQBHLLCH-UHFFFAOYSA-N

Associated Targets(Human)

HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhodesain Rhodesain (1463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cathepsin B-like cysteine protease (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 373.52Molecular Weight (Monoisotopic): 373.2387AlogP: 4.59#Rotatable Bonds: 5
Polar Surface Area: 34.94Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.14CX Basic pKa: 9.45CX LogP: -1.07CX LogD: -2.85
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.40Np Likeness Score: -0.27

References

1. Lavrado J, Paulo A, Gut J, Rosenthal PJ, Moreira R..  (2008)  Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity.,  18  (4): [PMID:18207399] [10.1016/j.bmcl.2008.01.015]
2. Lavrado J, Reszka AP, Moreira R, Neidle S, Paulo A..  (2010)  C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization.,  20  (23): [PMID:20952194] [10.1016/j.bmcl.2010.09.110]
3. Lavrado J, Cabal GG, Prudêncio M, Mota MM, Gut J, Rosenthal PJ, Díaz C, Guedes RC, dos Santos DJ, Bichenkova E, Douglas KT, Moreira R, Paulo A..  (2011)  Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies.,  54  (3): [PMID:21207937] [10.1021/jm101383f]
4. Lavrado J, Mackey Z, Hansell E, McKerrow JH, Paulo A, Moreira R..  (2012)  Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives.,  22  (19): [PMID:22926067] [10.1016/j.bmcl.2012.07.104]

Source